Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

How Insilico Medicine Uses AI To Accelerate Drug Development

Por: Forbes Tech November 09, 2022

thumbnail

Alex Zhavoronkov, co-founder and CEO of Insilico MedicineAlex Zhavoronkov Within the longevity research community, Alex Zhavoronkov is well-known for his relentless focus. He works seven days a week and takes no holidays. The hard work is paying off: In February, Insilico Medicine, the AI drug development company he founded, announced the first phase 1 clinical trials for a wholly AI-developed drug. Following a series of investment rounds in the... + full article



Similar News

F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market

The New York Times USA Health October 20, 2022

thumbnailA Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm births.Makena has been in use for 11 years, and the panel’s vote was widely of... + más

FDA panel recommends pulling preterm birth drug from the market | The Boston Globe

FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC


FDA panel recommends pulling preterm birth drug from the market

The Boston Globe USA Nation October 20, 2022

thumbnailA Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm birth.Makena has been in use for 11 years, and the panel’s vote was widely... + más

F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market | The New York Times

FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC


Drug meant to prevent premature births should be removed from market, FDA panel says

Los Angeles Times USA Science October 20, 2022

thumbnailA federal advisory panel voted Wednesday to recommend that the only approved drug to prevent premature birth be removed from pharmacy shelves because studies have shown it does not work. The 14-to-1 vote came more than a decade after the Food and Drug Administration approved the... + más

FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC

FDA panel backs removal of unproven pregnancy drug | Portland Press Herald


Drugs Should Be Priced Based On One Factor – Value

Forbes USA Tech October 20, 2022

thumbnailFor a number of years, the price of drugs has drawn extraordinary attention. Based on the current discourse, one would think that the nation’s healthcare costs were dominated by medicines. In reality, drugs account for less than 15% of all medical spending. Yet, the clamor... + más

Alberta To Be First Canadian Province To Regulate Psychedelics For Therapeutic Use | Forbes

How Is The Dow Jones Industrial Average Actually Calculated? | Forbes


FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth

CNBC USA Health October 19, 2022

thumbnailAn advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.The recommendation, in a 14-1 vote, from the agency's Obstetrics, Reproductive and... + más

FDA panel backs removal of unproven pregnancy drug | WPLG Local 10

ALS drug wins FDA approval despite questionable data | ABC News


FDA approves controversial new drug designed to slow the progression of ALS

CNBC USA Health September 29, 2022

thumbnailThe Food and Drug Administration on Thursday approved a controversial new drug designed to slow the progress of Lou Gehrig's disease, a victory for patients and advocates despite limited evidence that the drug is effective.The drug, from the Massachusetts-based , joins... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


How concierge medicine is changing the way people access health care

The Advocate USA Health September 17, 2022

thumbnailThe concierge medical market in the U.S. is expected to reach $13.3 billion by 2030, up from $6.1 billion in 2022, according to Research and Markets reports.What is concierge medicine? It’s a subscription-based model of primary care medicine. Most patients pay a membership fee... + más

Poll: Americans give health care system failing mark | 10 WBNS

May is Mental Health Awareness Month: COVID may have normalized mental health struggles | The Advocate



About iurex | Privacy Policy | Disclaimer |